Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Jesmin, Subrina ^a   Sakuma, Ichiro ^a   Togashi, Hiroko ^a   Yoshioka, Mitsuhiro ^a   Hattori, Yuichi ^a   Kitabatake, Akira ^a   Miyauchi, Takashi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelin (ET) antagonism; Frontal cortex; Spontaneously hypertensive stroke prone rats (SHR SP); Vascular endothelial growth factor (VEGF) and its receptor

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL TISSUE; BRAIN; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FRONTAL CORTEX; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; STROKE; UPREGULATION;

AGE FACTORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; HYPERTENSION; INDANS; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; STROKE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 11044222841     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166264.27476.60     Document Type: Conference Paper

References (21)

1. Okamoto K, Yamori Y, Nagaoka A. Establishment of the SHR-SPs (SHR). Circ Res. 1974;34:I-143-I-153.
2. Coyle P, Jokelainen PT. Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHR-SP) and Wistar Kyoto (WKY) rats. Stroke. 1983;14:605-611.
3. Duverger D, MacKenzie ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration and age. J Cereb Blood Flow Metab. 1988;8:449-461.
4. Coyle P, Heistad DD. Development of collaterals in the cerebral circulation. Blood Vessels. 1991;28:183-189.
5. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
6. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
7. Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5:519-524.
8. Ogunshola OO, Stewart WB, Mihalcik V, et al. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res. 2000;119:139-153.
9. Ie Noble FA, Stassen FR, Hacking WJ, et al. Angiogenesis and hypertension. J Hypertens. 1998;16:1563-1572.
10. Struijker Boudier HA, Ie Noble JL, Messing MW, et al. The microcirculation in hypertension. J Hypertens. 1992;10:S147.
11. Naruse M, Takagi S, Tanabe A, et al. Augmented expression of tissue endothelin-1 messenger RNA is a common feature in hypertensive rats. J Cardiovasc Pharmacol. 2000;36:S195-S197.
12. 1-adrenoceptor mRNA expression in rat heart. Biochem Pharmacol. 1999;58:881-885.
13. Felmeden DC, Spencer CG, Belgore FM, et al. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens. 2003;16:11-20.
14. Belgore FM, Blann AD, Li-Saw-Hee FL, et al. Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension. Am J Cardiol. 2001;87:805-807.
15. Tuder RM, Chacon M, Alger L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol. 2001;195:367-374.
16. Hutchins PM, Darnell AE. Observation of a decreased number of small arterioles in spontaneous hypertensive rats. Circ Res. 1994;34/35: 161-165.
17. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension. 1983;5:844-851.
18. Christou H, Yoshida A, Arthur V, et al. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 1998;18:768-776.
19. Savage P, Jeng AY. Upregulation of endothelin-1 binding in tissues of salt-loaded stroke-prone spontaneously hypertensive rats. Can J Physiol Pharmacol. 2002;80:470-474.
20. Pedram A, Rasandi M, Hu RM, et al. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem. 1997;272:17097-17103.
21. Salani D, Taraboletti G, Rosano L, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000;157:1703-1711.